Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ABIOMED(R) SHAREHOLDERS APPROVE CHANGES TO CORPORATE CHARTER.


DANVERS, MA, Aug. 10, 1995--(BUSINESS WIRE)--ABIOMED, Inc. (Nasdaq:ABMD ABMD areal bone mineral density
ABMD AEGIS Ballistic Missile Defense (US Navy)
ABMD Advanced Ballistic Missile Defense
) announced today that the Company's shareholders have adopted each of the provisions outlined its 1995 proxy. In particular, the shareholders approved provisions designed to grant the Board of Directors broader authority and increased negotiating leverage in evaluating potential business combinations, including directives allowing the Board to consider all relevant factors and constituencies in connection with certain business combination, adoption of staggered terms staggered terms

Membership terms for a firm's directors that expire in different years. A firm with 12 directors might have 4-year terms with 3 seats up for election each year. Staggered terms make it more difficult for a raider to gain control of a board.
 of office for members of the Board of Directors, and an increase in the number of common shares authorized Shares authorized

The maximum number of shares of stock of a company allowed in the articles of incorporation, which may be changed only by a shareholder vote. See: Issued and outstanding.


shares authorized

See authorized capital stock.
.

Commenting on these actions, Dr. David M. Lederman, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said, "ABIOMED has made significant operational and financial progress since the launch of the BVS-5000(R) two years ago. While the provisions adopted by the shareholders were not recommended in response to any known effort to acquire control of the Company, we believe that they will better enable the Company to continue to realize the potential of its proprietary technology and to build long-term shareholder value."

Based in Danvers, Massachusetts Danvers is a town in Essex County, Massachusetts, United States. Located on the Danvers River near the northeastern coast of Massachusetts, Danvers is most widely known for its association with the 1692 Salem witch trials. , ABIOMED, Inc. develops, manufactures and markets innovative cardiovascular, medical and dental products and is a leader in the research and development of heart support systems.

CONTACT: John F. Thero

Chief Financial Officer

Kristin T. Hurley Hurley has become the English version of at least three distinct original Irish names: the Ó hUirthile, part of the Dál gCais tribal group, based in Clare and North Tipperary; the Ó Muirthile, based around Kilbritain in west Cork; and the OhIarlatha, from the district of  

Executive Assistant

(508) 777-5410 Ext. 100

or

Betsy Brod/Alex Gleeson

Media Contact:

Lee Foley

Morgen-Walke Associates

(212) 850-5600
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 10, 1995
Words:227
Previous Article:QUALCOMM signs Fujitsu Ltd. as latest CDMA subscriber product licensee.
Next Article:Studio Plus Hotels Inc. releases earnings for the three month period ended June 30, 1995.
Topics:



Related Articles
ABIOMED Wins Federal Grant.
NIH Grant Awarded To ABIOMED To Develop Bioactive Adhesion System.
ABIOMED's BVS-5000 in the 100th Heart Transplant Center in the USA.
ABIOMED Reports Progress With Its Replacement Heart.
ABIOMED Receives FDA Approval for New Cannula.
ABIOMED Announces FDA Approval of New Transport Console.
ABIOMED Outlines Offer to Acquire Thermo Cardiosystems.
ABIOMED Withdraws Offers to Acquire Thermo Cardiosystems Inc.
ABIOMED Announces FDA Approvals for BVS-5000 Cardiac Support System.
Hahnemann University Hospital Provides Update On Fifth AbioCor Replacement Heart Patient.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles